… To address this issue, the Anticancer Fund, a Belgian non-profit organisation, launched My
Cancer Navigator in 2019. This free service offers people access to a team of scientists and …

… drug repurposing trials developed and maintained by the Anticancer Fund [13]. It records
active, … The selection of drugs comes from another Anticancer Fund database, the repurposing …

… Other organizations with a similar mandate exist, including the Belgium-based Anticancer
Fund, which has dedicated funding to repurpose drug cocktails to treat cancer (eg, metzolimos…

… The Repurposing Drugs in Oncology (ReDO) database, curated by Belgian non-for-profit
organization the Anticancer Fund, lists a total of 335 non-cancer drugs that have shown some …

… The Anticancer Fund is actively pursuing this innovative strategy, as exemplified by the
granting of an EMA orphan designation for propranolol in angiosarcoma. …

Pharmaceuticals are a major cost driver of cancer treatment, and access to many agents
with potential benefit is limited because of their high cost, both for individual patients and for …

Background: Mutations in the BRCA genes predispose to developing breast, ovarian and
other cancers. Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are one treatment …

… A few NPOs specifically solicit drug repurposing proposals through their RFPs (AntiCancer
Fund… The Anticancer Fund is also selectively funding the development of promising therapies. …

… Anticancer Fund, Strombeek-Bever, 1853, Belgium … We would like to thank G Bouche
at Anticancer Fund for his thoughtful comments on an earlier draft of this manuscript. …

Background: Patient selection for phase I trials in oncology is challenging. A typical inclusion
criterion for phase I studies is' life expectancy> 3 months', however overall survival (OS) of …